Investigation Report on Clopidogrel in China, 2018-2022

SKU ID :CRI-11931831 | Published Date: 02-Jul-2018 | No. of pages: 30
Table of Contents 1 Relevant Concepts of Clopidogrel 1.1 Indication 1.2 Development History of Clopidogrel in China 2 Market Overview of Clopidogrel in China 2.1 Patents and Government Approval on Clopidogrel 2.2 Major Manufacturers 2.3 Market Size 3 Investigation of Clopidogrel's Sales in China, 2013-2017 3.1 Sales Value 3.1.1 Overall Sales Value 3.1.2 Sales Value in Different Regions 3.2 Sales Volume 3.2.1 Overall Sales Volume 3.2.2 Sales Volume in Different Regions 4 Market Share of Clopidogrel Manufacturers in China, 2013-2017 4.1 Market Share by Sales Value 4.2 Market Share by Sales Volume 5 Clopidogrel in Different Dosage Forms, 2013-2017 5.1 Market Share of Clopidogrel in Different Dosage Forms by Sales Value 5.2 Market Share of Clopidogrel in Different Dosage Forms by Sales Volume 6 Reference Sale Price of Clopidogrel in Chinese Market, 2017-2018 6.1 Sanofi (Hangzhou) Pharmaceutical Co., Ltd. (Product Trade Name: Plavix) 6.2 Shenzhen Salubris Pharmaceuticals Co., Ltd. (Product Trade Name: Taijia) 6.3 Lepu Pharmaceuticals Co., Ltd. (Product Trade Name: Shuaitai) 6.4 Sanofi (Product Trade Name: Plavix) 7 Major Clopidogrel Manufacturers in Chinese Market, 2013-2017 7.1 Sanofi Pharmaceutical Co., Ltd. 7.1.1 Enterprise Profile 7.1.2 Sales of Clopidogrel of Sanofi (Hangzhou) in China 7.2 Shenzhen Salubris Pharmaceuticals Co., Ltd. 7.3 Lepu Pharmaceuticals Co., Ltd. 7.4 Sanofi 8 Prospects of Chinese Clopidogrel Market, 2018-2022 8.1 Forecast on Market Size 8.2 Forecast on Development Trend Table of Charts Chart Chinese Government Approval on Clopidogrel Chart Sales of Clopidogrel in China, 2013-2017 Chart Sales Value of Clopidogrel in China, 2013-2017 Chart Sales Value of Clopidogrel in Parts of China, 2013-2017 Chart Sales Volume of Clopidogrel in China, 2013-2017 Chart Sales Volume of Clopidogrel in Parts of China, 2013-2017 Chart Sales Value and Market Share of Clopidogrel of Sanofi (Hangzhou), 2013-2017 Chart Sales Value and Market Share of Clopidogrel of Shenzhen Salubris, 2013-2017 Chart Sales Value and Market Share of Clopidogrel Tablets in China, 2013-2017 Chart Sales Volume and Market Share of Clopidogrel Tablets in China, 2013-2017 Chart Sale Price of Clopidogrel of Sanofi (Hangzhou) in Several Chinese Cities, 2017 Chart Sale Price of Clopidogrel of Shenzhen Salubris in Several Chinese Cities, 2017 Chart Forecast on Clopidogrel's Sales in China, 2018-2022
1 Sanofi Pharmaceutical Co., Ltd. 2 Shenzhen Salubris Pharmaceuticals Co., Ltd. 3 Lepu Pharmaceuticals Co., Ltd. 4 Sanofi
  • PRICE
  • $2200
    $3300

Our Clients